Compound class

Metabolic and mitochondrial peptides

Mitochondrial peptides, hormones and other metabolic compounds.

Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.

The compounds here range from mitochondrial peptides to hormones. MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA,1 SS-31 is another name for elamipretide,2 and vasopressin is a polypeptide hormone.3 FDA's 2026 briefing did not identify clinical studies of MOTS-c given to humans and weighs against adding it to the 503A bulks list for compounding.1 A registered phase 2a study, recruiting in 2026, plans a fixed dose of MOTS-c by subcutaneous injection once daily for 12 weeks.4 Elamipretide was granted accelerated approval in the USA in September 2025,5 as Forzinity, to improve muscle strength in patients with Barth syndrome weighing at least 30 kg.6

Metabolic 15

Supplements 1

Where some figures in the list come from

  • Calcitonin: this row is human calcitonin; salmon calcitonin has its own row. Cibacalcin, a human calcitonin injection approved in the US in 1986, is listed as discontinued.7

Guides 6

Calculators 3

Logged in Milligram

Share of people who logged a dose in Milligram in the 90 days to 15 November 2026 who logged each compound.

  • MOTS-c12%
  • NAD+7%
  • SS-31 (Elamipretide)3%
  • 5-Amino-1MQ2%

MOTS-c, how often

  • Daily23%
  • Every other day42%
  • Twice a week25%
  • Weekly8%
  • Less often2%

NAD+, how often

  • Daily32%
  • Every other day36%
  • Twice a week27%
  • Weekly3%
  • Less often2%

SS-31 (Elamipretide), how often

  • Daily72%
  • Every other day21%
  • Twice a week5%
  • Weekly0%
  • Less often1%

5-Amino-1MQ, how often

  • Daily65%
  • Every other day21%
  • Twice a week10%
  • Weekly4%
  • Less often0%

How often: among people with three or more logged doses, by the average gap between their doses.

Aggregated and anonymous, shares of people only. Each compound not listed: too few people logged it to show a share. It describes what people set up in the app, not advice on what to take.

References 15

  1. US Food and Drug Administration. Evaluation of MOTS-c-related bulk drug substances (MOTS-c (free base) and MOTS-c acetate) for inclusion on the 503A bulk drug substances list. FDA briefing document, Pharmacy Compounding Advisory Committee, July 23-24, 2026 (dated 11 May 2026). 2026. fda.gov
  2. Reid Thompson W, Hornby B, Manuel R, et al. A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism. 2021. PMC7935714
  3. Par Health USA, LLC. Vasostrict (vasopressin) label, version 49. 2026. DailyMed label
  4. Hudson Biotech. MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity. ClinicalTrials.gov NCT07505745, 2026. NCT07505745
  5. Shirley M. Elamipretide: First Approval. 2026. PMID 41335372
  6. Forzinity (elamipretide hydrochloride) injection. US prescribing information, DailyMed. DailyMed label
  7. US Food and Drug Administration. Drugs@FDA: NDA 018470, Cibacalcin (calcitonin human). Read 19 November 2026. Drugs@FDA
  8. Antonin KH, et al. Colonic absorption of human calcitonin in man. Clin Sci (Lond) 1992. PMID 1335402
  9. Spiropent 0,02 mg Tabletten (clenbuterol hydrochloride). Fachinformation (German summary of product characteristics), Hikma document spc-de-spiropent-230901. German SmPC
  10. Eli Lilly and Company. Humulin R (insulin human) injection. US prescribing information, DailyMed record version 35, 2026. DailyMed label
  11. Eli Lilly and Company. Humalog (insulin lispro) injection. US prescribing information, DailyMed record version 87, 2026. DailyMed label
  12. AbbVie Inc. Synthroid (levothyroxine sodium) tablets. US prescribing information, DailyMed label version 1537, 2024. DailyMed label (Synthroid)
  13. Par Health USA, LLC. Calcitonin salmon nasal solution. US prescribing information, DailyMed record version 22, 2026. DailyMed label (nasal solution)
  14. Mylan Institutional LLC. Miacalcin (calcitonin salmon) injection, for subcutaneous or intramuscular use. US prescribing information, DailyMed record version 9. DailyMed label (injection)
  15. Saniona. A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate. ClinicalTrials.gov NCT03488719. NCT03488719

Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.